Mini Michael, MD

Associate Professor, Pediatric Nephrology Division
Texas Children’s Hospital/Baylor College of Medicine
Houston, Texas, United States

● Alnylam Pharmaceuticals (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Presentation(s):

• Efficacy and Safety of Lumasiran for Infants and Young Children With Primary Hyperoxaluria Type 1: 12-Month Analysis of the Phase 3 ILLUMINATE-B Trial

  Friday, April 22, 2022
  6:15 PM – 6:30 PM US MT